Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$10.7K
3.88K shares
What this filing means
SMALES KELLY plans to sell 3.88K shares of TRANSPHORM, INC. valued at approximately $10.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/20/2023ACC: 0001970051-23-000022
3.88K
Shares to sell
$10.7K
Approx. market value
656.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
COMMON STOCK
COMPENSATORY PAYMENT
11/20/2023
656.00Total acquired656.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/20/2023 | COMMON STOCK COMPENSATORY PAYMENT | 656.00 | — |
| Total | 656.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.23K
Market value
$8.8K
11/17/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
656.00
Market value
$1.9K
11/20/2023
Total
Units
3.88K
Value
$10.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/17/2023 | 3.23K | $8.8K | — | Completed |
| Planned — Approximate Date | ||||
11/20/2023 | 656.00 | $1.9K | NASDAQ | Planned |
| Total | 3.88K | $10.7K | ||